[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

H Lundbeck A/S ADR (HLUYY)

H Lundbeck A/S ADR (HLUYY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

H Lundbeck A/S ADR Ottiliavej 9 Valby Copenhagen G7 2500 DNK

www.lundbeck.com P: 45-3630-1311

Sector:

Medical

INDUSTRY GROUPING:

Large Cap Pharma

Description:

H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the world. Its products are targeted at disorders like depression and anxiety, schizophrenia, insomnia, Huntington's, epilepsies, Alzheimer's and Parkinson's diseases. The Company is involved in the development of new and improved drugs for the treatment of psychiatric and neurological disorders. H. Lundbeck A/S is headquartered in Copenhagen, Denmark.

Key Statistics

Overview:

Market Capitalization, $K 21,906,302
Enterprise Value, $K 21,906,956
Shares Outstanding, K 995,741
Float, K 995,741
% Float 100.00%
Short Volume Ratio 0.34
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 2,593 M
Annual Net Income, $ 209,690 K
Last Quarter Sales, $ 659,300 K
Last Quarter Net Income, $ 62,130 K

Growth:

1-Year Return -30.38%
3-Year Return -45.34%
5-Year Return -63.03%
5-Year Revenue Growth 11.62%
5-Year Earnings Growth 19.88%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.70 on 05/11/22
Next Earnings Date 08/17/22
Earnings Per Share ttm 1.97
EPS Growth vs. Prev Qtr 112.12%
EPS Growth vs. Prev Year -6.67%
Annual Dividend & Yield (Paid) 0.20 (0.91%)
Annual Dividend & Yield (Fwd) 0.20 (0.89%)
Most Recent Dividend 0.195 on 03/24/22
Next Ex-Dividends Date 03/24/22
Dividend Payable Date 04/05/22
Dividend Payout Ratio 9.93%

HLUYY Ratios

Ratio
Price/Earnings ttm 11.17
Price/Earnings forward 10.48
Price/Earnings to Growth N/A
Return-on-Equity % 13.74%
Return-on-Assets % 7.16%
Profit Margin % 8.09%
Debt/Equity 0.32
Price/Sales 8.45
Price/Cash Flow 6.54
Price/Book 1.58
Book Value/Share 13.97
Interest Coverage 0.00
60-Month Beta 0.68
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.